Neurology & Neurotherapeutics - NE Multiple Sclerosis Section

Research output

Research output per year 1986 2008 2009 2010 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 489 Article
• 119 Review article
• 42 Letter
• 21 Editorial
• 30 More
  • 15 Comment/debate
  • 10 Chapter
  • 3 Short survey
  • 1 Book
  • 1 Conference contribution

Research output per year

Research output per year

Search results

• 2007

  Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection

  Harp, C., Lee, J., Washington, D. L., Cameron, E., Olsen, G., Frohman, E., Racke, M. & Monson, N. L., Feb 2007, In: Journal of Neuroimmunology. 183, 1-2, p. 189-199 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Germinal Center 100%
  • Multiple Sclerosis 74%
  • Cerebrospinal Fluid 73%
  • B-Lymphocytes 65%
  • Mutation 15%
  54 Scopus citations

• Corticosteroids for Multiple Sclerosis: II. Application for Disease-Modifying Effects

  Shah, A., Eggenberger, E., Zivadinov, R., Stuve, O. & Frohman, E., Oct 2007, In: Neurotherapeutics. 4, 4, p. 627-632 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Adrenal Cortex Hormones 91%
  • Adrenocorticotropic Hormone 44%
  • Complementary Therapies 23%
  • Neutralizing Antibodies 22%
  5 Scopus citations

• Corticosteroids for Multiple Sclerosis: I. Application for Treating Exacerbations

  Frohman, E., Shah, A., Eggenberger, E., Metz, L., Zivadinov, R. & Stuve, O., Oct 2007, In: Neurotherapeutics. 4, 4, p. 618-626 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Adrenal Cortex Hormones 91%
  • Art 44%
  • Acute Disease 40%
  • Neurology 39%
  42 Scopus citations

• Ethical perspectives in neurology

  Okuda, D. T., Oct 2007, In: CONTINUUM Lifelong Learning in Neurology. 13, 5 MULTIPL.SCLEROSIS, p. 198-201 4 p.

  Research output: Contribution to journal › Article › peer-review

• Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

  Wolinsky, J. S., Narayana, P. A., O'Connor, P., Coyle, P. K., Ford, C., Johnson, K., Miller, A., Pardo, L., Kadosh, S., Ladkani, D., Kastrukoff, L., Duquette, P., Freedman, M., Debouverie, M., Lubetski, C., Edan, G., Roullet, E., Confavreux, C., Thompson, A., Blumhardt, L., & 60 othersHawkins, S., Scott, T., Wynn, D., Cooper, J., Thurston, S., Elias, S., Markowitz, C., Mattson, D., Noseworthy, J., Shuster, E., Carter, J., Lublin, F., Stuart, W., Kaufman, M., Birnbaum, G., Rammohan, K., Whitham, R., Mihai, C., Greenberg, S., Smith, C., Agius, M., Van Den Noort, S., Myers, L., Nelson, J., Goodin, D., Arnason, B., Bashir, K., Lynch, S., Coyle, P., Kamin, S., Sheremata, W., Mitchell, G., Goodman, A., Kachuck, N., Dunne, P., Lindsey, J. W., Frohman, E., Bowen, J., Brooks, B., Rose, J., Moses, H., Jeffrey, D., Cross, A., Lisak, R., Vollmer, T., Antel, J., Cutter, G., Metz, L., McFarland, H., Reingold, S., Lublin, F. D., Vainrub, I., Lambert, L., Zhong, F., Rasmituth, J., Momin, S., Kreitman, R., Shifroni, G., Pinchasi, I. & Stark, Y., Jan 1 2007, In: Annals of Neurology. 61, 1, p. 14-24 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Glatiramer Acetate 100%
  • Chronic Progressive Multiple Sclerosis 94%
  • Placebos 47%
  • Intention to Treat Analysis 26%
  • Clinical Trials Data Monitoring Committees 17%
  348 Scopus citations

• Idiopathic transverse myelitis: Corticosteroids, plasma exchange, or cyclophosphamide

  Greenberg, B. M., Thomas, K. P., Krishnan, C., Kaplin, A. I., Calabresi, P. A. & Kerr, D. A., May 2007, In: Neurology. 68, 19, p. 1614-1617 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Transverse Myelitis 100%
  • Plasma Exchange 84%
  • Cyclophosphamide 64%
  • Adrenal Cortex Hormones 56%
  • Spinal Cord Diseases 26%
  115 Scopus citations

• Is neuromyelitis optica distinct from multiple sclerosis? Something for "lumpers" and "splitters"

  Frohman, E. & Kerr, D., Jun 1 2007, In: Archives of neurology. 64, 6, p. 903-905 3 p.

  Research output: Contribution to journal › Article › peer-review
  17 Scopus citations

• Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

  Goodin, D. S., Frohman, E., Hurwitz, B., O'Connor, P. W., Oger, J. J., Reder, A. T. & Stevens, J. C., Mar 2007, In: Neurology. 68, 13, p. 977-984 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Biomedical Technology Assessment 100%
  • Interferon-beta 91%
  • Interferon beta-1a 83%
  • Neurology 83%
  • Neutralizing Antibodies 78%
  167 Scopus citations

• Optical coherence tomography and disease subtype in multiple sclerosis

  Pulicken, M., Gordon-Lipkin, E., Balcer, L. J., Frohman, E., Cutter, G. & Calabresi, P. A., Nov 2007, In: Neurology. 69, 22, p. 2085-2092 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Optical Coherence Tomography 100%
  • Multiple Sclerosis 88%
  • Optic Neuritis 81%
  • Nerve Fibers 62%
  • Eye 44%
  251 Scopus citations

• Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis

  Gordon-Lipkin, E., Chodkowski, B., Reich, D. S., Smith, S. A., Pulicken, M., Balcer, L. J., Frohman, E., Cutter, G. & Calabresi, P. A., Oct 2007, In: Neurology. 69, 16, p. 1603-1609 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Nerve Fibers 100%
  • Multiple Sclerosis 90%
  • Atrophy 88%
  • Optical Coherence Tomography 51%
  • Brain 50%
  350 Scopus citations

• W. Ian McDonald, MB, ChB, PhD (1933-2006): the multiple sclerosis physician-scientist of the 20th century.

  Frohman, E., Stuve, O. & Miller, D. H., Mar 2007, In: Archives of neurology. 64, 3, p. 452-454 3 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• Women with Voiding Dysfunction Secondary to Bladder Outlet Dyssynergia in the Setting of Multiple Sclerosis Do Not Demonstrate Significantly Elevated Intravesical Pressures

  Lemack, G. E., Frohman, E. & Ramnarayan, P., May 2007, In: Urology. 69, 5, p. 893-897 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Ataxia 100%
  • Multiple Sclerosis 83%
  • Urinary Bladder 75%
  • Pressure 61%
  • Urodynamics 27%
  21 Scopus citations
• 2006

  Altered CD4⁺/CD8⁺ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

  Stuve, O., Marra, C. M., Bar-Or, A., Niino, M., Cravens, P. D., Cepok, S., Frohman, E., Phillips, J. T., Arendt, G., Jerome, K. R., Cook, L., Grand'Maison, F., Hemmer, B., Monson, N. L. & Racke, M. K., 2006, In: Archives of neurology. 63, 10, p. 1383-1387 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Natalizumab 100%
  • Multiple Sclerosis 99%
  • Cerebrospinal Fluid 60%
  • Cells 49%
  • T-Lymphocytes 43%
  252 Scopus citations

• Azathioprine myelosuppression in multiple sclerosis: Characterizing thiopurine methyltransferase polymorphisms

  Frohman, E., Havrdova, E., Levinson, B. & Slanar, O., Feb 2006, In: Multiple Sclerosis. 12, 1, p. 108-111 4 p.

  Research output: Contribution to journal › Article › peer-review

  • thiopurine methyltransferase 100%
  • Azathioprine 71%
  • Thiopurine S methyltranferase deficiency 61%
  • Multiple Sclerosis 57%
  • Pancytopenia 40%
  6 Scopus citations

• EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis

  Filippi, M., Rocca, M. A., Arnold, D. L., Bakshi, R., Barkhof, F., De Stefano, N., Fazekas, F., Frohman, E. & Wolinsky, J. S., Apr 2006, In: European Journal of Neurology. 13, 4, p. 313-325 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Neuroimaging 100%
  • Multiple Sclerosis 97%
  • Magnetic Resonance Spectroscopy 92%
  • Guidelines 70%
  • Physiologic Monitoring 19%
  62 Scopus citations

• Immune surveillance in multiple sclerosis patients treated with natalizumab

  Stuve, O., Marra, C. M., Jerome, K. R., Cook, L., Cravens, P. D., Cepok, S., Frohman, E., Phillips, T., Arendt, G., Hemmer, B., Monson, N. L. & Racke, M. K., May 2006, In: Annals of Neurology. 59, 5, p. 743-747 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Natalizumab 100%
  • Multiple Sclerosis 61%
  • Cerebrospinal Fluid 60%
  • JC Virus 24%
  • Cell Count 19%
  395 Scopus citations

• Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis

  Fisher, J. B., Jacobs, D. A., Markowitz, C. E., Galetta, S. L., Volpe, N. J., Nano-Schiavi, M. L., Baier, M. L., Frohman, E., Winslow, H., Frohman, T. C., Calabresi, P. A., Maguire, M. G., Cutter, G. R. & Balcer, L. J., Feb 2006, In: Ophthalmology. 113, 2, p. 324-332 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Nerve Fibers 100%
  • Multiple Sclerosis 90%
  • Eye 58%
  • Optic Neuritis 30%
  • Contrast Sensitivity 28%
  555 Scopus citations

• Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion

  Winslow, H., Mickey, B. E. & Frohman, E., Jan 2006, In: Archives of neurology. 63, 1, p. 135-137 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Visual Illusion 100%
  • Sympathomimetics 91%
  • Illusions 89%
  • Corpus Callosum 78%
  • Lesion 66%
  18 Scopus citations

• Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis

  Lemack, G. E., Frohman, E., Zimmern, P. E., Hawker, K. & Ramnarayan, P., May 2006, In: Urology. 67, 5, p. 960-964 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Urodynamics 100%
  • Multiple Sclerosis 76%
  • Lower Urinary Tract Symptoms 20%
  • Residual Volume 20%
  • Datasets 13%
  31 Scopus citations
• 2005

  Acute pathological laughter

  Okuda, D. T., Chyung, A. S. C., Chin, C. T. & Waubant, E., Oct 2005, In: Movement Disorders. 20, 10, p. 1389-1390 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Cerebral Peduncle 100%
  • Laughter 96%
  • Crying 84%
  • Central Nervous System Diseases 71%
  • Gadolinium 70%
  15 Scopus citations

• Bacteraemia in the elderly: Predictors of outcome in an urban teaching hospital

  Greenberg, B. M., Atmar, R. L., Stager, C. E. & Greenberg, S. B., May 2005, In: Journal of Infection. 50, 4, p. 288-295 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Urban Hospitals 100%
  • Bacteremia 91%
  • Teaching Hospitals 83%
  • Elderly 60%
  • Gram-Positive Cocci 46%
  36 Scopus citations

• Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis

  Monson, N. L., Cravens, P. D., Frohman, E., Hawker, K. & Racke, M. K., Feb 2005, In: Archives of neurology. 62, 2, p. 258-264 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Chronic Progressive Multiple Sclerosis 96%
  • Rituximab 76%
  • Cerebrospinal Fluid 60%
  • Blood 54%
  194 Scopus citations

• Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: Analysis of risk factors at initial urologic evaluation

  Lemack, G. E., Hawker, K. & Frohman, E., May 2005, In: Urology. 65, 5, p. 854-857 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Urodynamics 65%
  • Incidence 55%
  • Kidney 45%
  • Ultrasonography 43%
  36 Scopus citations

• Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3

  Paula, S., Monson, N. & Ball, W. J., Aug 15 2005, In: Proteins: Structure, Function and Genetics. 60, 3, p. 382-391 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Cardiac Glycoside 100%
  • Digoxin 96%
  • Cardiac Glycosides 92%
  • Molecular Modeling 61%
  • Monoclonal Antibodies 49%
  12 Scopus citations

• Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients

  Monson, N. L., Brezinschek, H. P., Brezinschek, R. I., Mobley, A., Vaughan, G. K., Frohman, E. M., Racke, M. K. & Lipsky, P. E., Jan 2005, In: Journal of Neuroimmunology. 158, 1-2, p. 170-181 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Cerebrospinal Fluid 98%
  • B-Lymphocytes 87%
  • Clone Cells 22%
  • Mutation 15%
  65 Scopus citations
• 2004

  A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis

  Phillips, J. T., Rice, G., Frohman, E., Vande Gaer, L., Scott, T., Haas, J., Eggenberger, E., Freedman, M. S., Stuart, W., Cunha, L., Jacobs, L., Oger, J., Arnold, D., Murray, J., DiBiase, M., Jethwa, V. & Goelz, S., Apr 2004, In: Clinical Therapeutics. 26, 4, p. 511-521 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Prefil 100%
  • Interferon beta-1a 93%
  • Syringes 70%
  • Multiple Sclerosis 55%
  • Human Serum Albumin 37%
  30 Scopus citations

• Disease modifying agent related skin reactions in multiple sclerosis: Prevention, assessment, and management

  Frohman, E., Brannon, K., Alexander, S., Sims, D., Phillips, J. T., O'Leary, S., Hawker, K. & Racke, M. K., Jun 2004, In: Multiple Sclerosis. 10, 3, p. 302-307 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Skin 62%
  • Chronic Progressive Multiple Sclerosis 39%
  • Relapsing-Remitting Multiple Sclerosis 35%
  • Skin Manifestations 33%
  38 Scopus citations

• Hypergraphia in the age of computers

  Okuda, D. T. & Chung, S. S., Jun 22 2004, In: Neurology. 62, 12, p. 2329-2330 2 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Isolated relative afferent pupillary defect secondary to contralateral midbrain compression

  Chen, C. J., Scheufele, M., Sheth, M., Torabi, A., Hogan, R. N. & Frohman, E., Sep 2004, In: Archives of neurology. 61, 9, p. 1451-1453 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Pupil Disorders 100%
  • Compression 77%
  • Mesencephalon 70%
  • Defects 66%
  • Lesion 50%
  10 Scopus citations

• Naegleria fowleri hemorrhagic meningoencephalitis: Report of two fatalities in children

  Okuda, D. T., Hanna, H. J., Coons, S. W. & Bodensteiner, J. B., Mar 2004, In: Journal of child neurology. 19, 3, p. 231-233 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Central Nervous System Protozoal Infections 100%
  • Meningoencephalitis 75%
  • Naegleria 50%
  • Muscle Rigidity 41%
  • Immunochemistry 40%
  20 Scopus citations

• Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome

  Kumar, N. & Frohman, E., Apr 2004, In: Archives of neurology. 61, 4, p. 586-589 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Neurosarcoidosis 100%
  • Lesion 60%
  • Syndrome 56%
  • Manifestation 47%
  • Magnetic Resonance Imaging 47%
  41 Scopus citations
• 2003

  Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography

  Frohman, T. C., Frohman, E., O'Suilleabhain, P. E., Salter, A., Dewey, R. B., Hogan, R. N., Galetta, S., Lee, A. G., Straumann, D., Noseworthy, J., Zee, D., Corbett, J., Corboy, J., Rivera, V. M. & Kramer, P. D., Sep 23 2003, In: Neurology. 61, 6, p. 848-850 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Ophthalmoplegia 100%
  • Physicians 11%
  59 Scopus citations

• A new measure of dysconjugacy in INO: The first-pass amplitude

  Frohman, E., O'Suilleabhain, P. E., Dewey, R. B., Frohman, T. C. & Kramer, P. D., Jun 15 2003, In: Journal of the Neurological Sciences. 210, 1-2, p. 65-71 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Ophthalmoplegia 100%
  • Eye Movements 31%
  • Multiple Sclerosis 26%
  • Acceleration 14%
  • Eye 9%
  25 Scopus citations

• Are astrocytes central players in the pathophysiology of multiple sclerosis?

  De Keyser, J., Zeinstra, E. & Frohman, E., Jan 1 2003, In: Archives of neurology. 60, 1, p. 132-136 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Astrocytes 64%
  • Cells 49%
  • Antigen-Presenting Cells 36%
  • Suppression 28%
  74 Scopus citations

• Arterial thrombosis induced by IVIg and its treatment with tPA

  Okuda, D., Flaster, M., Frey, J. & Sivakumar, K., Jun 10 2003, In: Neurology. 60, 11, p. 1825-1826 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Intravenous Immunoglobulins 100%
  • Thrombosis 69%
  • Passive Immunization 54%
  • Viscosity 48%
  • Tissue Plasminogen Activator 47%
  50 Scopus citations

• Horizontal monocular saccadic failure: An unusual clinically isolated syndrome progressing to multiple sclerosis

  Frohman, E. & Frohman, T. C., Feb 1 2003, In: Multiple Sclerosis. 9, 1, p. 55-58 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Transverse Myelitis 81%
  • Abducens Nerve Diseases 80%
  • Pathologic Nystagmus 79%
  • Pontine Tegmentum 78%
  13 Scopus citations

• Levetiracetam for Phasic Spasticity in Multiple Sclerosis

  Hawker, K., Frohman, E. & Racke, M., Dec 2003, In: Archives of neurology. 60, 12, p. 1772-1774 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Levetiracetam 93%
  • Spasm 25%
  • Tonic 19%
  • Drugs 12%
  44 Scopus citations

• Naegleria fowleri meningoencephalitis

  Okuda, D. T. & Coons, S., Jul 2003, In: Neurology. 61, 1, p. E1

  Research output: Contribution to journal › Article › peer-review
  8 Scopus citations

• The utility of MRI in suspected MS: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology

  Frohman, E., Goodin, D. S., Calabresi, P. A., Corboy, J. R., Coyle, P. K., Filippi, M., Frank, J. A., Galetta, S. L., Grossman, R. I., Hawker, K., Kachuck, N. J., Levin, M. C., Phillips, J. T., Racke, M. K., Rivera, V. M. & Stuart, W. H., Sep 9 2003, In: Neurology. 61, 5, p. 602-611 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Biomedical Technology Assessment 100%
  • Neurology 83%
  • Gadolinium 56%
  • White Matter 23%
  • Magnetic Resonance Imaging 17%
  171 Scopus citations
• 2002

  Acquired sexual paraphilia in patients with multiple sclerosis

  Frohman, E., Frohman, T. C. & Moreault, A. M., 2002, In: Archives of neurology. 59, 6, p. 1006-1010 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Paraphilic Disorders 100%
  • Multiple Sclerosis 88%
  • Sexual 46%
  • Sexual Behavior 29%
  • Brain Lesion 17%
  35 Scopus citations

• Different patterns of bcl-6 and p53 gene mutations in tonsillar B cells indicate separate mutational mechanisms

  Yavuz, A. S., Monson, N. L., Yavuz, S., Grammer, A. C., Longo, N., Girschick, H. J. & Lipsky, P. E., Nov 2002, In: Molecular Immunology. 39, 7-8, p. 485-493 9 p.

  Research output: Contribution to journal › Article › peer-review

  • p53 Genes 100%
  • Germinal Center 80%
  • B-Lymphocytes 69%
  • Mutation 50%
  • Genes 18%
  9 Scopus citations

• Disease modifying therapies in multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American academy of neurology and the MS council for clinical practice guidelines

  Goodin, D. S., Frohman, E., Garmany, G. P., Halper, J., Likosky, W. H., Lublin, F. D., Silberberg, D. H., Stuart, W. H. & Van Den Noort, S., Jan 22 2002, In: Neurology. 58, 2, p. 169-178 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Biomedical Technology Assessment 100%
  • Neurology 83%
  • Practice Guidelines 73%
  • Multiple Sclerosis 69%
  • Glucocorticoids 24%
  780 Scopus citations

• Disease-modifying therapy in multiple sclerosis: Strategies for optimizing management

  Frohman, E., Phillips, T., Kokel, K., Van Pelt, J., O'Leary, S., Gross, S., Hawker, K. & Racke, M., Jan 1 2002, In: Neurologist. 8, 4, p. 227-236 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Interferon beta-1a 48%
  • Interferons 29%
  • Interferon beta-1b 24%
  • Glatiramer Acetate 23%
  36 Scopus citations

• Glatiramer acetate (Copaxone) therapy induces CD8⁺ T cell responses in patients with multiple sclerosis

  Karandikar, N. J., Crawford, M. P., Yan, S. X., Ratts, R. B., Brenchley, J. M., Ambrozak, D. R., Lovett-Racke, A. E., Frohman, E., Stastny, P., Douek, D. C., Koup, R. A. & Racke, M. K., 2002, In: Journal of Clinical Investigation. 109, 5, p. 641-649 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Glatiramer Acetate 100%
  • Multiple Sclerosis 60%
  • T-Lymphocytes 42%
  • poly(glutamic acid-alanine) 23%
  • Up-Regulation 16%
  177 Scopus citations

• Immunization and MS: A summary of published evidence and recommendations

  Rutschmann, O. T., McCrory, D. C., Matchar, D. B., Bourdette, D., Copperman, L., Coyle, P., DeStafano, F., Marrie, T., Miller, D., Phair, C., Richert, J., Goodin, D. S., Armon, C., Frohman, E., Goldman, R. S., Hammond, D., Hsu, C. Y., Kanner, A. M., Lefkowitz, D. S., Silverman, I. E., & 2 othersSloan, M. A. & So, Y. T., Dec 24 2002, In: Neurology. 59, 12, p. 1837-1843 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunization 100%
  • BCG Vaccine 54%
  • Chickenpox 48%
  • Tetanus 46%
  • Hepatitis B 38%
  100 Scopus citations

• Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: The versional dysconjugacy index Z score

  Frohman, E., Frohman, T. C., O'Suilleabhain, P. E., Zhang, H., Hawker, K., Racke, M. K., Frawley, W., Phillips, J. T. & Kramer, P. D., 2002, In: Journal of Neurology Neurosurgery and Psychiatry. 73, 1, p. 51-55 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Ophthalmoplegia 100%
  • Multiple Sclerosis 66%
  • Acceleration 36%
  • Saccades 11%
  • Eye Movements 9%
  52 Scopus citations

• The effects of horizontal head position (yaw axis) and step velocity on the vestibulo-ocular reflex

  Kramer, P., Frohman, E., Nuti, D. & Zee, D. S., 2002, In: Annals of the New York Academy of Sciences. 956, p. 530-532 3 p.

  Research output: Contribution to journal › Article › peer-review
• 2001

  A p74 common gamma receptor chain isoform facilitates IL-2 and IL-15 responses by the myelomonocytic cell line Tf-1β2

  Monson, N. L., Fenske, T. J., Wei, S., Okragly, A. J., De Jong, J. L. O., Haak-Frendscho, M., O'Shea, J., Djeu, J. & Sondel, P. M., 2001, In: Journal of Leukocyte Biology. 69, 3, p. 419-425 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Interleukin-15 100%
  • Interleukin-2 70%
  • Protein Isoforms 63%
  • Cell Line 46%
  • anti-c antibody 33%
  2 Scopus citations

• Autonomic regulation of neuroimmunological responses: Implications for multiple sclerosis

  Frohman, E., Monson, N. L., Lovett-Racke, A. E. & Racke, M. K., 2001, In: Journal of Clinical Immunology. 21, 2, p. 61-73 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Nervous System 92%
  • Immune System 89%
  • Communication 56%
  • Nervous System Trauma 46%
  18 Scopus citations

• Diagnosis and management of headache

  Lewis J.B., J. & Frohman, E., 2001, In: Obstetrics and gynecology clinics of North America. 28, 2, p. 205-224 20 p.

  Research output: Contribution to journal › Article › peer-review

  • Migraine Disorders 100%
  • Headache 85%
  • Tension-Type Headache 42%
  • Women's Health 35%
  • Subarachnoid Hemorrhage 34%
  10 Scopus citations